Skip to main content

Endovia Health Sciences, Inc.

EDVA
Exchange
NYSE
Industry
Beverages
SEC CIK
0001553788

No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Endovia Health Sciences, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of EDVA: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders1217+5
Shares69.4K108.4K+39.0K (+56.2%)
Value$260.9K$255.7K−$5.20K (−2.0%)

New holders (6)

Institutions that held Endovia Health Sciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to EDVA in Q3 2025
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP13,785$32.5K0.00%
HRT Financial LP13,185$31.0K0.00%
Citadel Advisors LLC12,426$29.3K0.00%
Tower Research Capital LLC (TRC)2,414$5.70K0.00%
Citigroup Inc15$350.00%
FMR LLC5$120.00%

Sold out (1)

Institutions that held Endovia Health Sciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of EDVA in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Raymond James Financial Inc61$229